UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 218

Sortiert nach

Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization

PloS one, 2013-02, Vol.8 (2), p.e55742

2013

Link zum Volltext

Verfügbarkeit prüfen

Dosing Therapeutic Radiopharmaceuticals in Obese Patients

International journal of molecular sciences, 2022-01, Vol.23 (2), p.818

2022

Link zum Volltext

Verfügbarkeit prüfen

Gamma camera characterization at high holmium-166 activity in liver radioembolization

EJNMMI physics, 2021-03, Vol.8 (1), p.22-22, Article 22

2021

Link zum Volltext

Verfügbarkeit prüfen

Intra-arterial versus standard intravenous administration of lutetium-177-DOTA-octreotate in patients with NET liver metastases: study protocol for a multicenter, randomized controlled trial (LUTIA trial)

Trials, 2020-02, Vol.21 (1), p.141-141, Article 141

2020

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the Targeting of a Staphylococcus-aureus -Infected Implant with a Radiolabeled Antibody In Vivo

International journal of molecular sciences, 2023-02, Vol.24 (5), p.4374

2023

Link zum Volltext

Verfügbarkeit prüfen

The physics of radioembolization

EJNMMI physics, 2018-11, Vol.5 (1), p.22-27, Article 22

2018

Link zum Volltext

Verfügbarkeit prüfen

Fast quantitative reconstruction with focusing collimators for liver SPECT

EJNMMI physics, 2018-12, Vol.5 (1), p.28-16, Article 28

2018

Link zum Volltext

Verfügbarkeit prüfen

Tolerability of concurrent external beam radiotherapy and [ 177 Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial)

BMC cancer, 2023-03, Vol.23 (1), p.268-268, Article 268

2023

Link zum Volltext

Verfügbarkeit prüfen

Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial)

BMC gastroenterology, 2018-06, Vol.18 (1), p.1-11, Article 84

2018

Link zum Volltext

Verfügbarkeit prüfen

Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry

EJNMMI research, 2023-07, Vol.13 (1), p.68-68, Article 68

2023

Link zum Volltext

Verfügbarkeit prüfen

A single preoperative blood test predicts postoperative sepsis and pneumonia after coronary bypass or open aneurysm surgery

European journal of clinical investigation, 2019-03, Vol.49 (3), p.e13055-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

PSMA PET/CT Identifies Intrapatient Variation in Salivary Gland Toxicity From Iodine-131 Therapy

Molecular imaging, 2020, Vol.19, p.153601212093499-1536012120934992

2020

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of the implementation of [68Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging

Insights into imaging, 2022-08, Vol.13 (1), p.132-132, Article 132

2022

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide therapy

EJNMMI research, 2022-02, Vol.12 (1), p.7-7, Article 7

2022

Link zum Volltext

Verfügbarkeit prüfen

Current research topics in FAPI theranostics: a bibliometric analysis

European journal of nuclear medicine and molecular imaging, 2023-03, Vol.50 (4), p.1014-1027

2023

Link zum Volltext

Verfügbarkeit prüfen

Prophylactic Medication during Radioembolization in Metastatic Liver Disease: Is It Really Necessary? A Retrospective Cohort Study and Systematic Review of the Literature

Diagnostics (Basel), 2023-12, Vol.13 (24), p.3652

2023

Link zum Volltext

Verfügbarkeit prüfen

Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study

The lancet oncology, 2020-04, Vol.21 (4), p.561-570

2020

Link zum Volltext

Verfügbarkeit prüfen

Baseline Imaging Derived Predictive Factors of Response Following [ 177 Lu]Lu-PSMA-617 Therapy in Salvage Metastatic Castration-Resistant Prostate Cancer: A Lesion- and Patient-Based Analysis

Biomedicines, 2022-07, Vol.10 (7), p.1575

2022

Link zum Volltext

Verfügbarkeit prüfen

Competition (‘Steal’ Phenomenon) between [68Ga]Ga-PSMA-11 Uptake in Prostate Tumor Tissue Versus Healthy Tissue

Pharmaceutics, 2021-05, Vol.13 (5), p.699

2021

Link zum Volltext

Verfügbarkeit prüfen

Dose–response relationship after yttrium-90-radioembolization with glass microspheres in patients with neuroendocrine tumor liver metastases

European journal of nuclear medicine and molecular imaging, 2022-04, Vol.49 (5), p.1700-1710

2022

Link zum Volltext

Verfügbarkeit prüfen

FDG PET/CT in Crohn’s disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity

European journal of nuclear medicine and molecular imaging, 2014-04, Vol.41 (4), p.605-614

2014

Link zum Volltext

Verfügbarkeit prüfen

Holmium-166 Radioembolization: Current Status and Future Prospective

Cardiovascular and interventional radiology, 2022-11, Vol.45 (11), p.1634-1645

2022

Link zum Volltext

Verfügbarkeit prüfen

[18F]mFBG PET-CT for detection and localisation of neuroblastoma: a prospective pilot study

European journal of nuclear medicine and molecular imaging, 2023-03, Vol.50 (4), p.1146-1157

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: A cohort study

European radiology, 2018-03, Vol.28 (3), p.920-928

2018

Link zum Volltext

Verfügbarkeit prüfen

The effect of intra-arterial angiotensin II on the hepatic tumor to non-tumor blood flow ratio for radioembolization: a systematic review

PloS one, 2014-01, Vol.9 (1), p.e86394

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 218

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(206)
Mit Volltextzugriff
(193)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(125)
Science & Technology
(120)
Life Sciences & Biomedicine
(118)
Radiology, Nuclear Medicine & Medical Imaging
(81)
Male
(70)
Radiology
(66)
Female
(60)
Medicine
(60)
Imaging
(59)
Nuclear Medicine
(58)
Medicine & Public Health
(57)
Microspheres
(53)
Middle Aged
(51)
Patients
(47)
Aged
(45)
Liver
(43)
Radioembolization
(43)
Oncology
(42)
Liver Neoplasms - Radiotherapy
(41)
Cardiology
(34)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Quantitative comparison of PET and Bremsstrahlung SPECT for imaging the in vivo yttrium-90 microsphere distribution after liver radioembolization

Dosing Therapeutic Radiopharmaceuticals in Obese Patients

Gamma camera characterization at high holmium-166 activity in liver radioembolization

Intra-arterial versus standard intravenous administration of lutetium-177-DOTA-octreotate in patients with NET liver metastases: study protocol for a multicenter, randomized controlled trial (LUTIA trial)

Evaluating the Targeting of a Staphylococcus-aureus -Infected Implant with a Radiolabeled Antibody In Vivo

The physics of radioembolization

Fast quantitative reconstruction with focusing collimators for liver SPECT

Tolerability of concurrent external beam radiotherapy and [ 177 Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial)

Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial)

Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry

A single preoperative blood test predicts postoperative sepsis and pneumonia after coronary bypass or open aneurysm surgery

PSMA PET/CT Identifies Intrapatient Variation in Salivary Gland Toxicity From Iodine-131 Therapy

Cost-effectiveness of the implementation of [68Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging

Inflammatory markers and long term hematotoxicity of holmium-166-radioembolization in liver-dominant metastatic neuroendocrine tumors after initial peptide receptor radionuclide therapy

Current research topics in FAPI theranostics: a bibliometric analysis

Prophylactic Medication during Radioembolization in Metastatic Liver Disease: Is It Really Necessary? A Retrospective Cohort Study and Systematic Review of the Literature

Additional holmium-166 radioembolisation after lutetium-177-dotatate in patients with neuroendocrine tumour liver metastases (HEPAR PLuS): a single-centre, single-arm, open-label, phase 2 study

Baseline Imaging Derived Predictive Factors of Response Following [ 177 Lu]Lu-PSMA-617 Therapy in Salvage Metastatic Castration-Resistant Prostate Cancer: A Lesion- and Patient-Based Analysis

Competition (‘Steal’ Phenomenon) between [68Ga]Ga-PSMA-11 Uptake in Prostate Tumor Tissue Versus Healthy Tissue

Dose–response relationship after yttrium-90-radioembolization with glass microspheres in patients with neuroendocrine tumor liver metastases

FDG PET/CT in Crohn’s disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity

Holmium-166 Radioembolization: Current Status and Future Prospective

[18F]mFBG PET-CT for detection and localisation of neuroblastoma: a prospective pilot study

Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: A cohort study

The effect of intra-arterial angiotensin II on the hepatic tumor to non-tumor blood flow ratio for radioembolization: a systematic review

Suchergebnisse filtern